We are live on ! Find out more
FAF

Fjarde Ap-fonden Portfolio holdings

AUM $20.9B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+11.51%
1 Year Est. Return
+36.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$11.3B
AUM Growth
+$505M
Cap. Flow
-$515M
Cap. Flow %
-4.54%
Top 10 Hldgs %
29.39%
Holding
580
New
21
Increased
130
Reduced
408
Closed
13

Top Buys

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$13.7M
2
IFF icon
International Flavors & Fragrances
IFF
+$11.6M
3
BALL icon
Ball Corp
BALL
+$10.6M
4
PYPL icon
PayPal
PYPL
+$10.4M
5
WM icon
Waste Management
WM
+$9.66M

Sector Composition

Rank Sector Weight
1 Technology 28.38%
2 Consumer Discretionary 13.64%
3 Financials 13.64%
4 Healthcare 13.56%
5 Communication Services 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGT icon
76
Target
TGT
$72.1B
$29.7M 0.26%
128,391
-9,500
-7% -$2.31M
ZTS icon
77
Zoetis
ZTS
$30.4B
$29.6M 0.26%
121,122
-4,930
-4% -$1.08M
ELV icon
78
Elevance Health
ELV
$90.8B
$29.2M 0.26%
62,962
-4,348
-6% -$1.83M
ADP icon
79
Automatic Data Processing
ADP
$110B
$28.5M 0.25%
115,496
-8,957
-7% -$2.03M
DE icon
80
Deere & Co
DE
$182B
$28.1M 0.25%
82,058
-3,723
-4% -$1.3M
GE icon
81
GE Aerospace
GE
$329B
$27.9M 0.25%
474,249
-28,731
-6% -$1.8M
BKNG icon
82
Booking.com
BKNG
$132B
$27.8M 0.24%
289,175
-15,000
-5% -$1.42M
NOW icon
83
ServiceNow
NOW
$147B
$27.2M 0.24%
209,895
-10,235
-5% -$1.34M
MDLZ icon
84
Mondelez International
MDLZ
$79.7B
$26.5M 0.23%
400,106
-2,600
-0.6% -$160K
PNC icon
85
PNC Financial Services
PNC
$97.4B
$26.4M 0.23%
131,783
-8,379
-6% -$1.71M
SYK icon
86
Stryker
SYK
$108B
$26.2M 0.23%
97,973
-7,400
-7% -$1.94M
EL icon
87
Estee Lauder
EL
$35.5B
$26.2M 0.23%
70,768
-2,100
-3% -$713K
MU icon
88
Micron Technology
MU
$1.04T
$25.9M 0.23%
277,540
-25,769
-8% -$2.01M
MMM icon
89
3M
MMM
$83.6B
$25.8M 0.23%
173,485
-4,572
-3% -$681K
IFF icon
90
International Flavors & Fragrances
IFF
$21.3B
$25.1M 0.22%
166,380
+79,369
+91% +$11.6M
LRCX icon
91
Lam Research
LRCX
$342B
$25M 0.22%
347,680
-27,690
-7% -$1.74M
GILD icon
92
Gilead Sciences
GILD
$182B
$24.5M 0.22%
336,994
-19,400
-5% -$1.34M
TJX icon
93
TJX Companies
TJX
$139B
$24M 0.21%
315,997
-22,300
-7% -$1.55M
CL icon
94
Colgate-Palmolive
CL
$69.2B
$23.7M 0.21%
277,309
+8,115
+3% +$634K
MRSH
95
Marsh
MRSH
$84.4B
$23.1M 0.2%
132,738
-11,880
-8% -$1.97M
EW icon
96
Edwards Lifesciences
EW
$49.3B
$23M 0.2%
177,468
-3,170
-2% -$370K
ADI icon
97
Analog Devices
ADI
$175B
$22.9M 0.2%
130,359
-20,100
-13% -$3.56M
CHTR icon
98
Charter Communications
CHTR
$17.4B
$22.4M 0.2%
34,426
-2,818
-8% -$1.92M
MRNA icon
99
Moderna
MRNA
$58.6B
$22.4M 0.2%
88,130
-4,930
-5% -$1.44M
SNOW icon
100
Snowflake
SNOW
$117B
$22.4M 0.2%
66,000
+2,700
+4% +$941K

Similar funds

Fjarde Ap-fonden's Q4 2021 Portfolio in Review

As of Q4 2021, Fjarde Ap-fonden held 580 positions worth $11.3B, up 4.7% from $10.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Fjarde Ap-fonden withdrew a net $515M in Q4 2021, closing 13 positions and reducing 408 holdings. Its most notable exit was Agilent Technologies, an estimated $13.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Fjarde Ap-fonden opened a new position in Dow Inc worth $13.7M.

  • Fjarde Ap-fonden's largest Q4 2021 buy was Dow Inc: 240,800 shares worth $13.7M.
  • Fjarde Ap-fonden added most to International Flavors & Fragrances in Q4 2021, an estimated $11.6M increase.
  • Fjarde Ap-fonden's biggest Q4 2021 reduction was Apple, cutting an estimated $49.9M.
  • Fjarde Ap-fonden fully exited Agilent Technologies in Q4 2021, selling an estimated $13.4M.
  • Fjarde Ap-fonden's ten largest holdings make up 29% of its $11.3B portfolio in Q4 2021.
  • Fjarde Ap-fonden opened 21 new positions and closed 13 in Q4 2021.
  • Fjarde Ap-fonden's portfolio value rose 4.7% quarter-over-quarter to $11.3B.

Based on Fjarde Ap-fonden's 13F filing for Q4 2021, filed 15 Feb 2022.